Condition
Uterine Cervical Neoplasms clinical trials and research
As of November 12, 2026, Find a Trial lists 23 Uterine Cervical Neoplasms clinical trials that are recruiting, at sites in 17 countries (most in China (8), France (5), South Korea (3)). By phase: Phase 3 (3), Phase 2 (3), Phase 1 (2), Phase 1/2 (2). The most active sponsors are Cancer Research UK (2), Zhejiang Cancer Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 23Clinical trials
- 17Countries
Newest Uterine Cervical Neoplasms clinical trials
All recruiting trials (23)
-
Enlonstobart with chemotherapy and radiotherapy for locally advanced cervical cancer
This study tests whether adding Enlonstobart to standard chemotherapy and chemoradiotherapy helps patients with locally advanced cervical cancer by increasing response rates and monitoring safety.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Immunotherapy Plus Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
This trial tests whether adding immunotherapy and chemotherapy to carbon ion radiotherapy can help women with locally advanced cervical cancer live longer without the cancer growing.
-
Dual PD1/CTLA4 immunotherapy with chemotherapy before surgery for locally advanced cervical cancer
This study tests a combo of a PD1/CTLA4 bispecific antibody with standard chemotherapy to see if it can improve outcomes before surgery in women with locally advanced cervical cancer.
-
Radiomic MRI model to predict response to chemoradiotherapy in locally advanced cervical cancer
This project tests whether MRI-based radiomic features can predict how women with locally advanced cervical cancer will respond to combined chemotherapy and radiation.
-
Post-therapy stress symptoms after gynecologic brachytherapy in cervical cancer
This study tests whether patients undergoing uterovaginal brachytherapy for cervical cancer develop post-traumatic stress symptoms and how these symptoms change over up to 5 years.
-
Interactive video plus navigator to help Black women get cervical cancer screening
This project will test whether an interactive video paired with an in-person navigator helps Black women who are overdue get cervical cancer screening more often than a standard educational video.
-
Exploring new imaging technology for cervical cancer surgery
This study is testing a new imaging technology to help doctors find cancer spread in lymph nodes during cervical cancer surgery to see if it can improve surgery results for patients.
-
Validation of a low-cost cervical cancer screening test
This study is testing a new, low-cost cervical cancer screening tool to see if it works as well as traditional methods for women in El Salvador.
-
Combining Disitamab Vedotin with Cisplatin for Cervical Cancer Treatment
This study is testing if a new combination of Disitamab Vedotin and cisplatin can help patients with advanced cervical cancer feel better and improve their chances of successful surgery.
-
Evaluating self-sampling versus clinician-sampling for HPV testing in cervical cancer screening
This study is testing if self-sampling for HPV testing can find more cases of high-risk HPV compared to traditional testing done by a doctor, to see if it could be a better option for cervical cancer screening.
-
Comparing two radiation therapy methods for high-risk cervical cancer after surgery
This study is testing two different radiation therapy methods to see which one works better for women with high-risk cervical cancer after surgery.
-
Evaluating LY4170156 for advanced solid tumors
This study is testing a new drug called LY4170156 to see if it is safe and effective for people with advanced solid tumors like ovarian and lung cancers.
-
Testing UCB4594 for advanced cancer treatment
This study is testing a new drug called UCB4594 to see if it can help treat advanced cancer by targeting a specific protein on cancer cells.
-
Evaluating HTL0039732 for Advanced Solid Tumours
This study is testing a new drug called HTL0039732, alone and with another treatment, to see if it can help people with advanced solid tumors by boosting their immune response against cancer.
-
Treatment for advanced cervical cancer using chemoradiotherapy and additional chemotherapy
This study is testing if adding extra chemotherapy to standard chemoradiotherapy can help people with advanced cervical cancer live longer and stay healthier.
-
Combining immunotherapy and chemoradiation for advanced cervical cancer
This study is testing if adding two immunotherapy drugs to standard treatment can help people with advanced cervical cancer live longer without their disease getting worse.
-
Adaptive Proton Therapy for Cervical Cancer
This study is testing if a new type of radiation therapy called intensity modulated proton therapy can help women with advanced cervical cancer have fewer side effects and better outcomes compared to standard radiation treatments.
-
Examining the effects of brachytherapy on gynecological cancers
This study looks at how well brachytherapy works for women aged 18 to 80 with different types of gynecological cancers.
-
Adjuvant chemotherapy for locally advanced cervical cancer patients not meeting NCCN guidelines
This study is testing if giving extra chemotherapy after surgery helps women with locally advanced cervical cancer who don’t meet standard treatment guidelines live longer and feel better.
-
Testing a new drug for advanced solid tumors
This study is testing a new drug called sigvotatug vedotin to see if it can safely help people with advanced solid tumors, both on its own and with other treatments.
-
Advanced treatment for locally advanced cervical cancer using image-guided techniques
This study is testing a new way to treat locally advanced cervical cancer using advanced imaging techniques to improve tumor control and reduce side effects for patients.
-
Database of patients with cervical cancer at Institut Paoli Calmettes
This study is creating a detailed database of cervical cancer patients to help understand the disease better and improve treatment for future patients.
Related topics
Quick answers
How many Uterine Cervical Neoplasms clinical trials are recruiting right now?
23, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in China (8 trials), France (5 trials), South Korea (3 trials), United Kingdom (3 trials), United States (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 3, Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.